A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

Investigator: Eamonn Quigley, MD

Study Coordinator: Melissa Whipple

Status: Enrolling

ClinicalTrials.gov Number: NCT05353985

Phone: 713.441.3247

Protocol Number: PRO00035979

Description

The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials